Completed NA INTERVENTIONAL 3-arm NCT02929992

Delivery Optimization for Antiretroviral Therapy (The DO ART Study) (DO ART)

Delivery Optimization for Antiretrovial Therapy (The DO ART Study): A Prospective, Interventional, Randomized Study of Community-based ART Initiation, Delivery, and Monitoring in South Africa and Uganda

Sponsor: Bill and Melinda Gates Foundation

Conditions ART HIV

Interventions ART initiation in the home Clinic ART Initiation Clinic ART Refill and Monitoring Mobile Van Refill and Monitoring

Updated 7 times since 2017 Last updated: Oct 27, 2020 Started: May 31, 2016 Primary completion: Nov 30, 2019 Completion: Jan 21, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates ART and HIV and is currently completed. Bill and Melinda Gates Foundation leads this study, which shows 7 recorded versions since 2016 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Nov 2020 — Jan 2021 [monthly]

Completed NA

Status: Recruiting → Completed
Nov 2018 — Nov 2020 [monthly]

Recruiting NA

▶ Show 2 earlier versions

Jun 2018 — Nov 2018 [monthly]

Recruiting NA
Jan 2017 — Jun 2018 [monthly]

Recruiting NA

First recorded

May 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bill and Melinda Gates Foundation
University of Washington

Data source: University of Washington

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kabwohe, Uganda
• Sweetwaters, South Africa